125 related articles for article (PubMed ID: 37587667)
1. Commentary on: "Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
Bright HR; Chandy SJ; George R
Acta Derm Venereol; 2023 Aug; 103():adv13348. PubMed ID: 37587667
[No Abstract] [Full Text] [Related]
2. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
[TBL] [Abstract][Full Text] [Related]
3. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
4. Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings.
Pottegård A; Bech BH; Pedersen SA; Christensen B
Pharmacoepidemiol Drug Saf; 2021 Nov; 30(11):1611-1616. PubMed ID: 34435407
[TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature.
Garrido PM; Borges-Costa J
Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):163-170. PubMed ID: 32354458
[TBL] [Abstract][Full Text] [Related]
6. The expanding saga of hydrochlorothiazide and skin cancer.
Heymann WR
J Am Acad Dermatol; 2019 Feb; 80(2):380-381. PubMed ID: 30529707
[No Abstract] [Full Text] [Related]
7. Hydrochlorothiazide and the risk of skin cancer. A scientific statement of the British and Irish Hypertension Society.
Faconti L; Ferro A; Webb AJ; Cruickshank JK; Chowienczyk PJ;
J Hum Hypertens; 2019 Apr; 33(4):257-258. PubMed ID: 30842544
[No Abstract] [Full Text] [Related]
8. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
9. Comment on "Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark".
van Veelen A; Nielen JTH; van Geel R; Croes S
J Am Acad Dermatol; 2021 Dec; 85(6):e357. PubMed ID: 30771418
[No Abstract] [Full Text] [Related]
10. Reply to "Comment on 'Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark'".
Pedersen SA; Pottegård A
J Am Acad Dermatol; 2021 Dec; 85(6):e359-e360. PubMed ID: 30771416
[No Abstract] [Full Text] [Related]
11. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer: a pilot study in the Brazilian population.
Tiba APL; Cury-Martins J; Miyashiro DR; Sanches JA
Int J Dermatol; 2022 Jun; 61(6):e213-e214. PubMed ID: 34480765
[No Abstract] [Full Text] [Related]
12. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
13. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
14. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
15. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Morales DR; Pacurariu A; Slattery J; Kurz X
Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906
[TBL] [Abstract][Full Text] [Related]
16. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.
Pedersen SA; Johannesdottir Schmidt SA; Hölmich LR; Friis S; Pottegård A; Gaist D
J Am Acad Dermatol; 2019 Feb; 80(2):460-465.e9. PubMed ID: 29913261
[TBL] [Abstract][Full Text] [Related]
17. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data.
Kim JC; Kim YC; Choi JW
Clin Exp Dermatol; 2021 Jun; 46(4):680-686. PubMed ID: 33215728
[TBL] [Abstract][Full Text] [Related]
18. [Hydrochlorothiazide and skin cancer].
Olde Engberink RHG; van der Hoeven NV; Zwinderman AH; van den Born BH
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120217
[TBL] [Abstract][Full Text] [Related]
19. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
Becquart O; Guillot B; Bourrain JL; Duflos C; Du-Thanh A
Rev Med Interne; 2019 Sep; 40(9):617-622. PubMed ID: 31101331
[TBL] [Abstract][Full Text] [Related]
20. In Brief: Hydrochlorothiazide and skin cancer.
Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
